Cost-Effectiveness of Routine Varicella Vaccination Using the Measles, Mumps, Rubella and Varicella Vaccine in France: An Economic Analysis Based on a Dynamic Transmission Model for Varicella and Herpes Zoster
Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves repla...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Littlewood, Kavi J. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2015transfer abstract |
|---|
| Schlagwörter: |
|---|
| Umfang: |
7588 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles - Zhou, Lixiao ELSEVIER, 2022, the international journal of drug therapy, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:37 ; year:2015 ; number:4 ; day:1 ; month:04 ; pages:830-8417 ; extent:7588 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.clinthera.2015.01.006 |
|---|
| Katalog-ID: |
ELV018243126 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV018243126 | ||
| 003 | DE-627 | ||
| 005 | 20230625123723.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clinthera.2015.01.006 |2 doi | |
| 028 | 5 | 2 | |a GBVA2015004000017.pica |
| 035 | |a (DE-627)ELV018243126 | ||
| 035 | |a (ELSEVIER)S0149-2918(15)00015-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 690 |a 610 |a 600 |q VZ |
| 084 | |a 30.00 |2 bkl | ||
| 084 | |a 44.13 |2 bkl | ||
| 100 | 1 | |a Littlewood, Kavi J. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cost-Effectiveness of Routine Varicella Vaccination Using the Measles, Mumps, Rubella and Varicella Vaccine in France: An Economic Analysis Based on a Dynamic Transmission Model for Varicella and Herpes Zoster |
| 264 | 1 | |c 2015transfer abstract | |
| 300 | |a 7588 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs. | ||
| 520 | |a Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs. | ||
| 650 | 7 | |a zoster |2 Elsevier | |
| 650 | 7 | |a economic analysis |2 Elsevier | |
| 650 | 7 | |a France |2 Elsevier | |
| 650 | 7 | |a dynamic model |2 Elsevier | |
| 650 | 7 | |a varicella |2 Elsevier | |
| 650 | 7 | |a vaccination |2 Elsevier | |
| 700 | 1 | |a Ouwens, Mario J.N.M. |4 oth | |
| 700 | 1 | |a Sauboin, Christophe |4 oth | |
| 700 | 1 | |a Tehard, Bertrand |4 oth | |
| 700 | 1 | |a Alain, Sophie |4 oth | |
| 700 | 1 | |a Denis, François |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Zhou, Lixiao ELSEVIER |t Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles |d 2022 |d the international journal of drug therapy |g Amsterdam [u.a.] |w (DE-627)ELV007757921 |
| 773 | 1 | 8 | |g volume:37 |g year:2015 |g number:4 |g day:1 |g month:04 |g pages:830-8417 |g extent:7588 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.clinthera.2015.01.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 30.00 |j Naturwissenschaften allgemein: Allgemeines |q VZ |
| 936 | b | k | |a 44.13 |j Medizinische Ökologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 37 |j 2015 |e 4 |b 1 |c 0401 |h 830-8417 |g 7588 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
k j l kj kjl |
|---|---|
| matchkey_str |
littlewoodkavijouwensmariojnmsauboinchri:2015----:otfetvnsoruieaielvciainsnteesemmsueladaielvcienrnencnmcnlssaeoayai |
| hierarchy_sort_str |
2015transfer abstract |
| bklnumber |
30.00 44.13 |
| publishDate |
2015 |
| allfields |
10.1016/j.clinthera.2015.01.006 doi GBVA2015004000017.pica (DE-627)ELV018243126 (ELSEVIER)S0149-2918(15)00015-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 610 600 VZ 30.00 bkl 44.13 bkl Littlewood, Kavi J. verfasserin aut Cost-Effectiveness of Routine Varicella Vaccination Using the Measles, Mumps, Rubella and Varicella Vaccine in France: An Economic Analysis Based on a Dynamic Transmission Model for Varicella and Herpes Zoster 2015transfer abstract 7588 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs. Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs. zoster Elsevier economic analysis Elsevier France Elsevier dynamic model Elsevier varicella Elsevier vaccination Elsevier Ouwens, Mario J.N.M. oth Sauboin, Christophe oth Tehard, Bertrand oth Alain, Sophie oth Denis, François oth Enthalten in Elsevier Science Zhou, Lixiao ELSEVIER Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles 2022 the international journal of drug therapy Amsterdam [u.a.] (DE-627)ELV007757921 volume:37 year:2015 number:4 day:1 month:04 pages:830-8417 extent:7588 https://doi.org/10.1016/j.clinthera.2015.01.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 30.00 Naturwissenschaften allgemein: Allgemeines VZ 44.13 Medizinische Ökologie VZ AR 37 2015 4 1 0401 830-8417 7588 045F 610 |
| spelling |
10.1016/j.clinthera.2015.01.006 doi GBVA2015004000017.pica (DE-627)ELV018243126 (ELSEVIER)S0149-2918(15)00015-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 610 600 VZ 30.00 bkl 44.13 bkl Littlewood, Kavi J. verfasserin aut Cost-Effectiveness of Routine Varicella Vaccination Using the Measles, Mumps, Rubella and Varicella Vaccine in France: An Economic Analysis Based on a Dynamic Transmission Model for Varicella and Herpes Zoster 2015transfer abstract 7588 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs. Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs. zoster Elsevier economic analysis Elsevier France Elsevier dynamic model Elsevier varicella Elsevier vaccination Elsevier Ouwens, Mario J.N.M. oth Sauboin, Christophe oth Tehard, Bertrand oth Alain, Sophie oth Denis, François oth Enthalten in Elsevier Science Zhou, Lixiao ELSEVIER Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles 2022 the international journal of drug therapy Amsterdam [u.a.] (DE-627)ELV007757921 volume:37 year:2015 number:4 day:1 month:04 pages:830-8417 extent:7588 https://doi.org/10.1016/j.clinthera.2015.01.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 30.00 Naturwissenschaften allgemein: Allgemeines VZ 44.13 Medizinische Ökologie VZ AR 37 2015 4 1 0401 830-8417 7588 045F 610 |
| allfields_unstemmed |
10.1016/j.clinthera.2015.01.006 doi GBVA2015004000017.pica (DE-627)ELV018243126 (ELSEVIER)S0149-2918(15)00015-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 610 600 VZ 30.00 bkl 44.13 bkl Littlewood, Kavi J. verfasserin aut Cost-Effectiveness of Routine Varicella Vaccination Using the Measles, Mumps, Rubella and Varicella Vaccine in France: An Economic Analysis Based on a Dynamic Transmission Model for Varicella and Herpes Zoster 2015transfer abstract 7588 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs. Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs. zoster Elsevier economic analysis Elsevier France Elsevier dynamic model Elsevier varicella Elsevier vaccination Elsevier Ouwens, Mario J.N.M. oth Sauboin, Christophe oth Tehard, Bertrand oth Alain, Sophie oth Denis, François oth Enthalten in Elsevier Science Zhou, Lixiao ELSEVIER Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles 2022 the international journal of drug therapy Amsterdam [u.a.] (DE-627)ELV007757921 volume:37 year:2015 number:4 day:1 month:04 pages:830-8417 extent:7588 https://doi.org/10.1016/j.clinthera.2015.01.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 30.00 Naturwissenschaften allgemein: Allgemeines VZ 44.13 Medizinische Ökologie VZ AR 37 2015 4 1 0401 830-8417 7588 045F 610 |
| allfieldsGer |
10.1016/j.clinthera.2015.01.006 doi GBVA2015004000017.pica (DE-627)ELV018243126 (ELSEVIER)S0149-2918(15)00015-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 610 600 VZ 30.00 bkl 44.13 bkl Littlewood, Kavi J. verfasserin aut Cost-Effectiveness of Routine Varicella Vaccination Using the Measles, Mumps, Rubella and Varicella Vaccine in France: An Economic Analysis Based on a Dynamic Transmission Model for Varicella and Herpes Zoster 2015transfer abstract 7588 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs. Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs. zoster Elsevier economic analysis Elsevier France Elsevier dynamic model Elsevier varicella Elsevier vaccination Elsevier Ouwens, Mario J.N.M. oth Sauboin, Christophe oth Tehard, Bertrand oth Alain, Sophie oth Denis, François oth Enthalten in Elsevier Science Zhou, Lixiao ELSEVIER Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles 2022 the international journal of drug therapy Amsterdam [u.a.] (DE-627)ELV007757921 volume:37 year:2015 number:4 day:1 month:04 pages:830-8417 extent:7588 https://doi.org/10.1016/j.clinthera.2015.01.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 30.00 Naturwissenschaften allgemein: Allgemeines VZ 44.13 Medizinische Ökologie VZ AR 37 2015 4 1 0401 830-8417 7588 045F 610 |
| allfieldsSound |
10.1016/j.clinthera.2015.01.006 doi GBVA2015004000017.pica (DE-627)ELV018243126 (ELSEVIER)S0149-2918(15)00015-6 DE-627 ger DE-627 rakwb eng 610 610 DE-600 690 610 600 VZ 30.00 bkl 44.13 bkl Littlewood, Kavi J. verfasserin aut Cost-Effectiveness of Routine Varicella Vaccination Using the Measles, Mumps, Rubella and Varicella Vaccine in France: An Economic Analysis Based on a Dynamic Transmission Model for Varicella and Herpes Zoster 2015transfer abstract 7588 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs. Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs. zoster Elsevier economic analysis Elsevier France Elsevier dynamic model Elsevier varicella Elsevier vaccination Elsevier Ouwens, Mario J.N.M. oth Sauboin, Christophe oth Tehard, Bertrand oth Alain, Sophie oth Denis, François oth Enthalten in Elsevier Science Zhou, Lixiao ELSEVIER Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles 2022 the international journal of drug therapy Amsterdam [u.a.] (DE-627)ELV007757921 volume:37 year:2015 number:4 day:1 month:04 pages:830-8417 extent:7588 https://doi.org/10.1016/j.clinthera.2015.01.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 30.00 Naturwissenschaften allgemein: Allgemeines VZ 44.13 Medizinische Ökologie VZ AR 37 2015 4 1 0401 830-8417 7588 045F 610 |
| language |
English |
| source |
Enthalten in Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles Amsterdam [u.a.] volume:37 year:2015 number:4 day:1 month:04 pages:830-8417 extent:7588 |
| sourceStr |
Enthalten in Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles Amsterdam [u.a.] volume:37 year:2015 number:4 day:1 month:04 pages:830-8417 extent:7588 |
| format_phy_str_mv |
Article |
| bklname |
Naturwissenschaften allgemein: Allgemeines Medizinische Ökologie |
| institution |
findex.gbv.de |
| topic_facet |
zoster economic analysis France dynamic model varicella vaccination |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles |
| authorswithroles_txt_mv |
Littlewood, Kavi J. @@aut@@ Ouwens, Mario J.N.M. @@oth@@ Sauboin, Christophe @@oth@@ Tehard, Bertrand @@oth@@ Alain, Sophie @@oth@@ Denis, François @@oth@@ |
| publishDateDaySort_date |
2015-01-01T00:00:00Z |
| hierarchy_top_id |
ELV007757921 |
| dewey-sort |
3610 |
| id |
ELV018243126 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV018243126</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625123723.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.clinthera.2015.01.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015004000017.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV018243126</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0149-2918(15)00015-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="a">610</subfield><subfield code="a">600</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">30.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Littlewood, Kavi J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cost-Effectiveness of Routine Varicella Vaccination Using the Measles, Mumps, Rubella and Varicella Vaccine in France: An Economic Analysis Based on a Dynamic Transmission Model for Varicella and Herpes Zoster</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7588</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">zoster</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">economic analysis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">France</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">dynamic model</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">varicella</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">vaccination</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ouwens, Mario J.N.M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sauboin, Christophe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tehard, Bertrand</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alain, Sophie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Denis, François</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Zhou, Lixiao ELSEVIER</subfield><subfield code="t">Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles</subfield><subfield code="d">2022</subfield><subfield code="d">the international journal of drug therapy</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007757921</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:37</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:4</subfield><subfield code="g">day:1</subfield><subfield code="g">month:04</subfield><subfield code="g">pages:830-8417</subfield><subfield code="g">extent:7588</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.clinthera.2015.01.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">30.00</subfield><subfield code="j">Naturwissenschaften allgemein: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">37</subfield><subfield code="j">2015</subfield><subfield code="e">4</subfield><subfield code="b">1</subfield><subfield code="c">0401</subfield><subfield code="h">830-8417</subfield><subfield code="g">7588</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Littlewood, Kavi J. |
| spellingShingle |
Littlewood, Kavi J. ddc 610 ddc 690 bkl 30.00 bkl 44.13 Elsevier zoster Elsevier economic analysis Elsevier France Elsevier dynamic model Elsevier varicella Elsevier vaccination Cost-Effectiveness of Routine Varicella Vaccination Using the Measles, Mumps, Rubella and Varicella Vaccine in France: An Economic Analysis Based on a Dynamic Transmission Model for Varicella and Herpes Zoster |
| authorStr |
Littlewood, Kavi J. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007757921 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 690 - Buildings 600 - Technology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 690 610 600 VZ 30.00 bkl 44.13 bkl Cost-Effectiveness of Routine Varicella Vaccination Using the Measles, Mumps, Rubella and Varicella Vaccine in France: An Economic Analysis Based on a Dynamic Transmission Model for Varicella and Herpes Zoster zoster Elsevier economic analysis Elsevier France Elsevier dynamic model Elsevier varicella Elsevier vaccination Elsevier |
| topic |
ddc 610 ddc 690 bkl 30.00 bkl 44.13 Elsevier zoster Elsevier economic analysis Elsevier France Elsevier dynamic model Elsevier varicella Elsevier vaccination |
| topic_unstemmed |
ddc 610 ddc 690 bkl 30.00 bkl 44.13 Elsevier zoster Elsevier economic analysis Elsevier France Elsevier dynamic model Elsevier varicella Elsevier vaccination |
| topic_browse |
ddc 610 ddc 690 bkl 30.00 bkl 44.13 Elsevier zoster Elsevier economic analysis Elsevier France Elsevier dynamic model Elsevier varicella Elsevier vaccination |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
m j o mj mjo c s cs b t bt s a sa f d fd |
| hierarchy_parent_title |
Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles |
| hierarchy_parent_id |
ELV007757921 |
| dewey-tens |
610 - Medicine & health 690 - Building & construction 600 - Technology |
| hierarchy_top_title |
Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV007757921 |
| title |
Cost-Effectiveness of Routine Varicella Vaccination Using the Measles, Mumps, Rubella and Varicella Vaccine in France: An Economic Analysis Based on a Dynamic Transmission Model for Varicella and Herpes Zoster |
| ctrlnum |
(DE-627)ELV018243126 (ELSEVIER)S0149-2918(15)00015-6 |
| title_full |
Cost-Effectiveness of Routine Varicella Vaccination Using the Measles, Mumps, Rubella and Varicella Vaccine in France: An Economic Analysis Based on a Dynamic Transmission Model for Varicella and Herpes Zoster |
| author_sort |
Littlewood, Kavi J. |
| journal |
Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles |
| journalStr |
Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2015 |
| contenttype_str_mv |
zzz |
| container_start_page |
830 |
| author_browse |
Littlewood, Kavi J. |
| container_volume |
37 |
| physical |
7588 |
| class |
610 610 DE-600 690 610 600 VZ 30.00 bkl 44.13 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Littlewood, Kavi J. |
| doi_str_mv |
10.1016/j.clinthera.2015.01.006 |
| dewey-full |
610 690 600 |
| title_sort |
cost-effectiveness of routine varicella vaccination using the measles, mumps, rubella and varicella vaccine in france: an economic analysis based on a dynamic transmission model for varicella and herpes zoster |
| title_auth |
Cost-Effectiveness of Routine Varicella Vaccination Using the Measles, Mumps, Rubella and Varicella Vaccine in France: An Economic Analysis Based on a Dynamic Transmission Model for Varicella and Herpes Zoster |
| abstract |
Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs. |
| abstractGer |
Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs. |
| abstract_unstemmed |
Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| container_issue |
4 |
| title_short |
Cost-Effectiveness of Routine Varicella Vaccination Using the Measles, Mumps, Rubella and Varicella Vaccine in France: An Economic Analysis Based on a Dynamic Transmission Model for Varicella and Herpes Zoster |
| url |
https://doi.org/10.1016/j.clinthera.2015.01.006 |
| remote_bool |
true |
| author2 |
Ouwens, Mario J.N.M. Sauboin, Christophe Tehard, Bertrand Alain, Sophie Denis, François |
| author2Str |
Ouwens, Mario J.N.M. Sauboin, Christophe Tehard, Bertrand Alain, Sophie Denis, François |
| ppnlink |
ELV007757921 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1016/j.clinthera.2015.01.006 |
| up_date |
2024-07-06T18:21:56.419Z |
| _version_ |
1803854929116266496 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV018243126</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625123723.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.clinthera.2015.01.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015004000017.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV018243126</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0149-2918(15)00015-6</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">690</subfield><subfield code="a">610</subfield><subfield code="a">600</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">30.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Littlewood, Kavi J.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cost-Effectiveness of Routine Varicella Vaccination Using the Measles, Mumps, Rubella and Varicella Vaccine in France: An Economic Analysis Based on a Dynamic Transmission Model for Varicella and Herpes Zoster</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7588</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Each year in France, varicella and zoster affect large numbers of children and adults, resulting in medical visits, hospitalizations for varicella- and zoster-related complications, and societal costs. Disease prevention by varicella vaccination is feasible, wherein a plausible option involves replacing the combined measles, mumps, and rubella (MMR) vaccine with the combined MMR and varicella (MMRV) vaccine. This study aimed to: (1) assess the cost-effectiveness of adding routine varicella vaccination through MMRV, using different vaccination strategies in France; and (2) address key uncertainties, such as the economic consequences of breakthrough varicella cases, the waning of vaccine-conferred protection, vaccination coverage, and indirect costs.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">zoster</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">economic analysis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">France</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">dynamic model</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">varicella</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">vaccination</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ouwens, Mario J.N.M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sauboin, Christophe</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tehard, Bertrand</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alain, Sophie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Denis, François</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Zhou, Lixiao ELSEVIER</subfield><subfield code="t">Repression of autophagy leads to acrosome biogenesis disruption caused by a sub-chronic oral administration of polystyrene nanoparticles</subfield><subfield code="d">2022</subfield><subfield code="d">the international journal of drug therapy</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007757921</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:37</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:4</subfield><subfield code="g">day:1</subfield><subfield code="g">month:04</subfield><subfield code="g">pages:830-8417</subfield><subfield code="g">extent:7588</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.clinthera.2015.01.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">30.00</subfield><subfield code="j">Naturwissenschaften allgemein: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.13</subfield><subfield code="j">Medizinische Ökologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">37</subfield><subfield code="j">2015</subfield><subfield code="e">4</subfield><subfield code="b">1</subfield><subfield code="c">0401</subfield><subfield code="h">830-8417</subfield><subfield code="g">7588</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3975134 |